Evidence map›Paper›PMID 27153397›Full record

ArticleAmerican journal of human genetics2016

Mechanisms and Disease Associations of Haplotype-Dependent Allele-Specific DNA Methylation.

Catherine Do, Charles F Lang, John Lin, Huferesh Darbary, Izabela Krupska, Aulona Gaba, Lynn Petukhova, Jean-Paul Vonsattel, Mary P Gallagher, Robin S Goland and 6 more

Open access · bronzeAbstract readComparative Study
In one paragraph

Article in American journal of human genetics, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 80 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
80citing papers in PubMed, 2 pooled it
8.4field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

80 citing papers in PubMed, 2 syntheses or guidelines pooled it, 140 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Expanding Upon Genomics in Rare Diseases: Epigenomic Insights.International journal of molecular sciences · 2024
    Review
  13. Article
  14. Article
  15. Article
  16. Epigenomic insights into common human disease pathology.Cellular and molecular life sciences : CMLS · 2024
    Review
  17. Article
  18. Article
  19. Article
  20. Article

20 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 4 institutions in 2 countries.

Catherine DoInstitute for Cancer Genetics, Columbia University, New York, NY 10032, USA. Electronic address: cd2695@columbia.edu.
Charles F LangInstitute for Cancer Genetics, Columbia University, New York, NY 10032, USA.
John LinInstitute for Cancer Genetics, Columbia University, New York, NY 10032, USA.
Huferesh DarbaryInstitute for Cancer Genetics, Columbia University, New York, NY 10032, USA.
Izabela KrupskaInstitute for Cancer Genetics, Columbia University, New York, NY 10032, USA.
Aulona GabaInstitute for Cancer Genetics, Columbia University, New York, NY 10032, USA; Department of Obstetrics and Gynecology, Vienna Medical University, Vienna 1090, Austria.
Lynn PetukhovaDepartments of Epidemiology and Dermatology, Columbia University, New York, NY 10032, USA.
Jean-Paul VonsattelDepartments of Pathology and Cell Biology, Columbia University, New York, NY 10032, USA.
Mary P GallagherDivision of Pediatric Endocrinology, Diabetes and Metabolism, Columbia University, New York, NY 10032, USA.
Robin S GolandNaomi Berrie Diabetes Center, Columbia University, New York, NY 10032, USA.
Raphael A ClynesDepartments of Pathology, Medicine, and Dermatology, Columbia University, New York, NY 10032, USA.
Andrew DworkDepartments of Pathology and Cell Biology, Columbia University, New York, NY 10032, USA.
John G KralDepartments of Surgery, Medicine, and Cell Biology, SUNY Downstate Medical Center, Brooklyn, NY 11203, USA.
Catherine MonkDepartments of Psychiatry and Behavioral Medicine and Obstetrics and Gynecology, Columbia University, New York, NY 10032, USA.
Angela M ChristianoDepartments of Dermatology, Genetics, and Development, Columbia University, New York, NY 10032, USA.
Benjamin TyckoInstitute for Cancer Genetics, Columbia University, New York, NY 10032, USA; Departments of Pathology and Cell Biology, Columbia University, New York, NY 10032, USA. Electronic address: bt12@columbia.edu.
Columbia University · USCancer Genetics (United States) · USMedical University of Vienna · ATSUNY Downstate Health Sciences University · US

Funding

Two-Spirit Films in Indigenous Cancer HealthP30CA016056 · NCI · ROSWELL PARK CANCER INSTITUTE CORP · PI Dean G. Tang · 1985 to 2026
$116.6M
Epigenetic events underlying Type I diabetesDP3DK094400 · NIDDK · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI CHRISTIANO, ANGELA M, CLYNES, RAPHAEL A. · 2011 to 2011
$6.6M
Prenatal stress: the epigenetic basis of maternal and perinatal effectsR01MH092580 · NIMH · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI CHAMPAGNE, FRANCES A., MONK, CATHERINE E · 2011 to 2015
$3.4M
Epigenomics of Alzheimer's DiseaseR01AG036040 · NIA · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI MAYEUX, RICHARD P, TYCKO, BENJAMIN · 2009 to 2013
$3.3M
Allele-specific Mapping in Alzheimer's DiseaseR01AG035020 · NIA · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI MAYEUX, RICHARD P, TYCKO, BENJAMIN · 2010 to 2014
$592k
DNA Elements Underlying Celiac and Crohn's SusceptibilityR21AI133140 · NIAID · HACKENSACK UNIVERSITY MEDICAL CENTER · PI TYCKO, BENJAMIN · 2017 to 2018
$489k
NCI NIH HHS P30 CA016056NIAID NIH HHS R21 AI133140NIA NIH HHS R01 AG035020NIA NIH HHS R01 AG036040NIDDK NIH HHS DP3 DK094400NIMH NIH HHS R01 MH092580
6 · The paper itself

Abstract

Haplotype-dependent allele-specific methylation (hap-ASM) can impact disease susceptibility, but maps of this phenomenon using stringent criteria in disease-relevant tissues remain sparse. Here we apply array-based and Methyl-Seq approaches to multiple human tissues and cell types, including brain, purified neurons and glia, T lymphocytes, and placenta, and identify 795 hap-ASM differentially methylated regions (DMRs) and 3,082 strong methylation quantitative trait loci (mQTLs), most not previously reported. More than half of these DMRs have cell type-restricted ASM, and among them are 188 hap-ASM DMRs and 933 mQTLs located near GWAS signals for immune and neurological disorders. Targeted bis-seq confirmed hap-ASM in 12/13 loci tested, including CCDC155, CD69, FRMD1, IRF1, KBTBD11, and S100A(∗)-ILF2, associated with immune phenotypes, MYT1L, PTPRN2, CMTM8 and CELF2, associated with neurological disorders, NGFR and HLA-DRB6, associated with both immunological and brain disorders, and ZFP57, a trans-acting regulator of genomic imprinting. Polymorphic CTCF and transcription factor (TF) binding sites were over-represented among hap-ASM DMRs and mQTLs, and analysis of the human data, supplemented by cross-species comparisons to macaques, indicated that CTCF and TF binding likelihood predicts the strength and direction of the allelic methylation asymmetry. These results show that hap-ASM is highly tissue specific; an important trans-acting regulator of genomic imprinting is regulated by this phenomenon; and variation in CTCF and TF binding sites is an underlying mechanism, and maps of hap-ASM and mQTLs reveal regulatory sequences underlying supra- and sub-threshold GWAS peaks in immunological and neurological disorders.

Indexed as

DNA MethylationGenomic ImprintingQuantitative Trait LociAllelesAnimalsBrainFemaleGenome-Wide Association StudyHaplotypesHumansImmune System DiseasesMacaca mulattaMacaca radiataNervous System DiseasesPlacentaPolymorphism, Single NucleotideTrans-Activators

Identifiers

PMID27153397
PMCPMC4863666
OpenAlexW2346832371

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.